Carasent AB Stock Oslo Bors
Stocks
CARA
SE0023261599
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time
Oslo Bors
18:45:00 04/12/2024 +03
|
5-day change | 1st Jan Change | ||
| 21.10 NOK | +3.94% |
|
-.--% | - |
| 09-29 | SB1 Markets still sees strong ARR growth for Carasent - reiterates buy | FW |
| 09-14 | Lannebo Hälsa och Ny Teknik rose 5.9% in August, Bico among the month's winners | FW |
| Market Cap | 1.67B 174M 155M 145M 132M 248M 16.82B 250M 1.74B 680M 8.55B 653M 639M 27.5B | P/E 2026 * |
76.6x | P/E 2027 * | 30.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.67B 175M 156M 146M 132M 249M 16.89B 251M 1.75B 683M 8.59B 656M 641M 27.61B | EV / Sales 2026 * |
4.05x | EV / Sales 2027 * | 3.16x |
| Free-Float |
73.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent AB
| 1 day | +3.94% |
| 3 years | 9.81 |  | 21.3 |
| 5 years | 9.81 | | 47.35 |
| 10 years | 2 | | 51 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.94% | -.--% | - | - | 177M | |
| +0.83% | -2.58% | +21.71% | +32.80% | 243B | |
| +1.34% | -3.37% | +3.20% | +0.58% | 152B | |
| +2.41% | +0.57% | -7.82% | +40.19% | 143B | |
| -1.45% | -5.24% | -57.00% | -20.22% | 61.14B | |
| -0.81% | -2.61% | +12.04% | +16.39% | 49.85B | |
| -0.14% | -3.39% | +19.41% | +52.83% | 47.74B | |
| +1.29% | -0.23% | -20.20% | -18.72% | 47.74B | |
| -0.35% | +1.41% | -5.76% | +34.78% | 45.9B | |
| -2.11% | -1.56% | +165.06% | +91.23% | 41.3B | |
| Average | +0.85% | -1.17% | +14.52% | +25.54% | 92.33B | |
| Weighted average by Cap. | +1.01% | -1.28% | +9.95% | +24.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 413M 43.16M 38.57M 35.98M 32.68M 61.55M 4.18B 62.01M 432M 169M 2.12B 162M 159M 6.83B | 505M 52.68M 47.07M 43.92M 39.89M 75.13M 5.1B 75.69M 528M 206M 2.59B 198M 194M 8.33B |
| Net income | 23.47M 2.45M 2.19M 2.04M 1.85M 3.49M 237M 3.52M 24.54M 9.59M 121M 9.2M 9M 387M | 59.54M 6.22M 5.55M 5.18M 4.71M 8.86M 601M 8.93M 62.26M 24.33M 306M 23.33M 22.83M 983M |
| Net Debt | 7.2M 752K 672K 627K 569K 1.07M 72.73M 1.08M 7.53M 2.94M 36.99M 2.82M 2.76M 119M | -70.79M -7.39M -6.6M -6.16M -5.6M -10.54M -715M -10.62M -74.03M -28.92M -364M -27.75M -27.15M -1.17B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARAO Stock
- CARA Stock
Select your edition
All financial news and data tailored to specific country editions
